Request Deal Involvement
Horizon Therapeutics completed the acquisition of the sterile fill‑finish manufacturing facility from EirGen Pharma for $65m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Cooley
pr advisors
Gordon MRM
or
Principals
target
EIRGEN PHARMA (STERILE FILL AND FINISH MANUFACTURING FACILITY)
vendor
EIRGEN PHARMA LTD
bidder
HORIZON THERAPEUTICS
vendor
OPKO HEALTH INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2026 Datasite